Wikipedia -WSS

Wikipedia

author：explore 2025-08-10 11:42:36 - browse：784

Neurocrine Biosciences decided to join PhRMA. Adobe

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： A controversial new treatment promises to make little people taller

WSS

Change Healthcare cyberattack outage could last weeks

H.R. 3 is the wrong path to lower drug costs

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Flint parents haunted by uncertainty, fears of lead poisoning

FDA approves Sage Therapeutics’ rapid

Study links childhood stress with decline in older age

hotspot

Wikipedia

hotspot

Continuity nursing helped my family in our darkest PICU moments

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Guidelines to prevent youth baseball injuries need more muscle

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

How to save PrEP access — and even expand it

How to fix the rural physician shortage in the U.S.

ChatGPT in medicine: STAT answers readers' burning questions

Alnylam reports growth in sales of rare disease treatments

As demand for Covid shots wanes, Moderna seeks its next success

A controversial new treatment promises to make little people taller

focus

'Null' research findings aren't empty of meaning. Let's publish them

RSV vaccines may be linked to small increased risk of developing GBS

H.R. 3 is the wrong path to lower drug costs

House looks to weaken Medicare negotiation

ALS groups 'won't be played again' by the FDA, drug sponsors

Obesity now affects over 1 billion people worldwide, study finds

hotspot

explore

knowledge

entertainment